180 related articles for article (PubMed ID: 24227374)
1. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Roset PN
Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
[No Abstract] [Full Text] [Related]
2. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373
[No Abstract] [Full Text] [Related]
3. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
Guest JF; Davie AM; Clegg JP
Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Squires H; Simpson E; Meng Y; Harnan S; Stevens J; Wong R; Thomas S; Michaels J; Stansby G
Health Technol Assess; 2011 Dec; 15(40):1-210. PubMed ID: 22142554
[TBL] [Abstract][Full Text] [Related]
7. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
Hong H; Mackey WC
Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of cilostazol and other therapies for intermittent claudication.
Dawson DL
Am J Cardiol; 2001 Jun; 87(12A):19D-27D. PubMed ID: 11434896
[TBL] [Abstract][Full Text] [Related]
9. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication?
Weismantel D
J Fam Pract; 2001 Feb; 50(2):181. PubMed ID: 11219570
[No Abstract] [Full Text] [Related]
10. Treatment of intermittent claudication: cilostazol.
Collins P; Brittenden J
Hosp Med; 2004 Aug; 65(8):466-70. PubMed ID: 15330347
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment of intermittent claudication.
Jacoby D; Mohler ER
Drugs; 2004; 64(15):1657-70. PubMed ID: 15257627
[TBL] [Abstract][Full Text] [Related]
12. [The antagonist of type-II serotonin receptors naftidrofuryl in the treatment of patients with intermittent claudication].
Komarov AL; Panchenko EP; Eshkeeva AR; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA
Ter Arkh; 1996; 68(2):49-53. PubMed ID: 8771659
[TBL] [Abstract][Full Text] [Related]
13. Can claudication be improved with medication?
Conners MS; Money SR
Semin Vasc Surg; 2002 Dec; 15(4):237-44. PubMed ID: 12478498
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of intermittent claudication.
Doggrell SA
Expert Opin Pharmacother; 2001 Nov; 2(11):1725-36. PubMed ID: 11825312
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
Girolami B; Bernardi E; Prins MH; Ten Cate JW; Hettiarachchi R; Prandoni P; Girolami A; Büller HR
Arch Intern Med; 1999 Feb; 159(4):337-45. PubMed ID: 10030306
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
Dawson DL; Cutler BS; Hiatt WR; Hobson RW; Martin JD; Bortey EB; Forbes WP; Strandness DE
Am J Med; 2000 Nov; 109(7):523-30. PubMed ID: 11063952
[TBL] [Abstract][Full Text] [Related]
17. Treatment with pharmacological agents in peripheral arterial disease patients does not result in biomechanical gait changes.
Huisinga JM; Pipinos II; Stergiou N; Johanning JM
J Appl Biomech; 2010 Aug; 26(3):341-8. PubMed ID: 20841626
[TBL] [Abstract][Full Text] [Related]
18. Exercise and peripheral arterial disease.
Kim DH
Ann Intern Med; 2006 May; 144(9):699; author reply 699-700. PubMed ID: 16670144
[No Abstract] [Full Text] [Related]
19. The effect of withdrawal of drugs treating intermittent claudication.
Dawson DL; DeMaioribus CA; Hagino RT; Light JT; Bradley DV; Britt KE; Charles BE
Am J Surg; 1999 Aug; 178(2):141-6. PubMed ID: 10487267
[TBL] [Abstract][Full Text] [Related]
20. New treatment options in intermittent claudication: the US experience.
Hiatt WR
Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
